Global Pegfilgrastim Market Growth 2019-2024

Published On: Jan 2019

Format: PDF

Publisher: LP Infomation

Pages: 135

Report ID: 224522

Pegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the production of white blood cells (neutrophils).

According to this study, over the next five years the Pegfilgrastim market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Pegfilgrastim business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Pegfilgrastim market by product type, application, key manufacturers and key regions and countries.

This study considers the Pegfilgrastim value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
Pegfilgrastim
Pegfilgrastim Biosimilar
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drug store

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Amgen
Mylan
Coherus BioSciences
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Pegfilgrastim consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Pegfilgrastim market by identifying its various subsegments.
Focuses on the key global Pegfilgrastim manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pegfilgrastim with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pegfilgrastim submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Pegfilgrastim Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pegfilgrastim Consumption 2013-2023
2.1.2 Pegfilgrastim Consumption CAGR by Region
2.2 Pegfilgrastim Segment by Type
2.2.1 Pegfilgrastim
2.2.2 Pegfilgrastim Biosimilar
2.3 Pegfilgrastim Consumption by Type
2.3.1 Global Pegfilgrastim Consumption Market Share by Type (2013-2018)
2.3.2 Global Pegfilgrastim Revenue and Market Share by Type (2013-2018)
2.3.3 Global Pegfilgrastim Sale Price by Type (2013-2018)
2.4 Pegfilgrastim Segment by Application
2.4.1 Hospital
2.4.2 Drug store
2.5 Pegfilgrastim Consumption by Application
2.5.1 Global Pegfilgrastim Consumption Market Share by Application (2013-2018)
2.5.2 Global Pegfilgrastim Value and Market Share by Application (2013-2018)
2.5.3 Global Pegfilgrastim Sale Price by Application (2013-2018)

3 Global Pegfilgrastim by Players
3.1 Global Pegfilgrastim Sales Market Share by Players
3.1.1 Global Pegfilgrastim Sales by Players (2016-2018)
3.1.2 Global Pegfilgrastim Sales Market Share by Players (2016-2018)
3.2 Global Pegfilgrastim Revenue Market Share by Players
3.2.1 Global Pegfilgrastim Revenue by Players (2016-2018)
3.2.2 Global Pegfilgrastim Revenue Market Share by Players (2016-2018)
3.3 Global Pegfilgrastim Sale Price by Players
3.4 Global Pegfilgrastim Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Pegfilgrastim Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Pegfilgrastim Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Pegfilgrastim by Regions
4.1 Pegfilgrastim by Regions
4.1.1 Global Pegfilgrastim Consumption by Regions
4.1.2 Global Pegfilgrastim Value by Regions
4.2 Americas Pegfilgrastim Consumption Growth
4.3 APAC Pegfilgrastim Consumption Growth
4.4 Europe Pegfilgrastim Consumption Growth
4.5 Middle East & Africa Pegfilgrastim Consumption Growth

5 Americas
5.1 Americas Pegfilgrastim Consumption by Countries
5.1.1 Americas Pegfilgrastim Consumption by Countries (2013-2018)
5.1.2 Americas Pegfilgrastim Value by Countries (2013-2018)
5.2 Americas Pegfilgrastim Consumption by Type
5.3 Americas Pegfilgrastim Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Pegfilgrastim Consumption by Countries
6.1.1 APAC Pegfilgrastim Consumption by Countries (2013-2018)
6.1.2 APAC Pegfilgrastim Value by Countries (2013-2018)
6.2 APAC Pegfilgrastim Consumption by Type
6.3 APAC Pegfilgrastim Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Pegfilgrastim by Countries
7.1.1 Europe Pegfilgrastim Consumption by Countries (2013-2018)
7.1.2 Europe Pegfilgrastim Value by Countries (2013-2018)
7.2 Europe Pegfilgrastim Consumption by Type
7.3 Europe Pegfilgrastim Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Pegfilgrastim by Countries
8.1.1 Middle East & Africa Pegfilgrastim Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Pegfilgrastim Value by Countries (2013-2018)
8.2 Middle East & Africa Pegfilgrastim Consumption by Type
8.3 Middle East & Africa Pegfilgrastim Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Pegfilgrastim Distributors
10.3 Pegfilgrastim Customer

11 Global Pegfilgrastim Market Forecast
11.1 Global Pegfilgrastim Consumption Forecast (2018-2023)
11.2 Global Pegfilgrastim Forecast by Regions
11.2.1 Global Pegfilgrastim Forecast by Regions (2018-2023)
11.2.2 Global Pegfilgrastim Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Pegfilgrastim Forecast by Type
11.8 Global Pegfilgrastim Forecast by Application

12 Key Players Analysis
12.1 Amgen
12.1.1 Company Details
12.1.2 Pegfilgrastim Product Offered
12.1.3 Amgen Pegfilgrastim Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Amgen News
12.2 Mylan
12.2.1 Company Details
12.2.2 Pegfilgrastim Product Offered
12.2.3 Mylan Pegfilgrastim Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Mylan News
12.3 Coherus BioSciences
12.3.1 Company Details
12.3.2 Pegfilgrastim Product Offered
12.3.3 Coherus BioSciences Pegfilgrastim Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Coherus BioSciences News
...

13 Research Findings and Conclusion